drug

In: Artificial Intelligence

In the pharmaceutical industry, biotechnology and healthcare companies face an unprecedented challenge for efficiently managing and analyzing vast amounts of drug-related data from diverse sources. Traditional data analysis methods prove inadequate for processing complex medical documentation that includes a mix of text, images, graphs, and tables. Amazon Bedrock offers featuresContinue Reading

In: Finance

Artur Plawgo uniQure (NASDAQ:QURE) shares traded higher premarket Tuesday after the Dutch biotech posted the latest data from its Phase 1/2 clinical trials for AMT-130, an investigational gene therapy for Huntington’s disease, a rare, inherited neurodegenerative disorder. Based on a Mar. 31 data cut of 21 patients, the company saidContinue Reading

In: Finance

spawns Hutchmed (NASDAQ:HCM) ADRs traded higher on Friday after regulators in China agreed to review the company’s lymphoma therapy tazemetostat, developed and sold in partnership with Ipsen (OTCPK:IPSEY). China’s National Medical Products Administration (NMPA) granted priority review for the new drug application (NDA) targeting adults with relapsed or refractory (“R/R”)Continue Reading

In: Finance

mohd izzuan/iStock via Getty Images With the cost of prescription drugs soaring by nearly 40% over the past decade, affordability concerns have forced about a third of Americans to leave their prescriptions unfilled at the pharmacy, drug-saving platform GoodRx Holdings (GDRX) said in a report this week. According to GoodRx’sContinue Reading

In: Finance

Sundry Photography Merck (NYSE:MRK) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed its lung disease therapy Winrevair in combination with other medications for certain adults with pulmonary arterial hypertension (PAH). EMA’s Committee for Medicinal Products for Human Use (CHMP) issued aContinue Reading